Guan-zhang Li

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilities.

Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilities.

Journal: Neuro-oncology

Published: August 05, 2025

EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis.

EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis.

Journal: Genes

Published: January 20, 2023

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.

Journal: EBioMedicine

Published: April 12, 2022

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development.

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development.

Journal: Chinese neurosurgical journal

Published: February 28, 2022

MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.

MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.

Journal: Journal for immunotherapy of cancer

Published: September 09, 2021

Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.

Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.

Journal: British journal of cancer

Published: February 18, 2021

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas.

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas.

Journal: Frontiers in cell and developmental biology

Published: July 06, 2020

Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.

Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.

Journal: Journal of cellular and molecular medicine

Published: June 29, 2020

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.

Journal: Frontiers in cell and developmental biology

Published: March 15, 2020

Classification of diffuse lower-grade glioma based on immunological profiling.

Classification of diffuse lower-grade glioma based on immunological profiling.

Journal: Molecular oncology

Published: February 12, 2020

Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.

Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.

Journal: The Journal of pathology

Published: December 18, 2019

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

Journal: JCI insight

Published: August 14, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026